Abstract
Recent economic improvement in Brazil has been reflected in better maternal–child health indicators, with decreases in infant and perinatal mortality. However, under-five mortality due to congenital disorders remained unchanged, and congenital disorders have become the second leading cause of infant mortality. In the present study, we used the PHG Foundation Health Needs Assessment (HNA) Toolkit with the objective of first assessing the burden of disease caused by neural tube defects (NTDs) in Brazil and the impact of interventions already put in place to address the burden, and second to evaluate and prioritize further interventions and policies required for its prevention and treatment. The results from these two components of the HNA process are described in this paper. The published literature was reviewed to identify studies of NTDs (prevalence; morbidity; prenatal, perinatal, and postnatal mortality; treatment or prevention). Data on indicators of maternal and child health were obtained directly from the Brazilian Ministry of Health, through the online Live Births Information System (SINASC) and from the Mortality Information System (SIM). Descriptive analyses included reports of the rates of NTD in liveborns, fetal, and infant deaths. Differences between folic acid flour pre-fortification (2001–2004) and post-fortification (2006–2010) periods were expressed as prevalence rate ratios. Around 20 % of fetal deaths were related to congenital disorders with approximately 5 % of those being NTDs. For infant mortality, congenital disorders were notified in approximately 15 % of cases, with NTDs present in 10 % of the malformed children. Although statistically significant, the prevalence rate ratio (PRR) for spina bifida in live births was only 0.937 (95 % confidence interval (CI) 0.884–0.994), a decrease of 6.3 % when comparing the pre and post-fortification periods. The impact of fortification seemed to be more visible in fetal deaths due to anencephaly (PRR = 0.727, 95 % CI 0.681–0.777) and for spina bifida (PRR = 0.700, 95 % CI 0.507–0.967) with associated decreases of 27.3 and 30 %. The lower impact of folic acid fortification in Brazil, compared to other Latin-American countries, can be due to differences in dietary habits, concentration of folic acid in flour, as well as characteristic population ethnic composition. The HNA led to the identification of the needs to be addressed in Brazil, including the improvement of reporting congenital disorders within the nationwide birth certification system, and revision of the policy of flour folic acid fortification.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Au KS, Ashley-Koch A, Northrup H (2010) Epidemiologic and genetic aspects of spina bifida and other neural tube defects. Dev Disabil Res Rev 16(1):6–15
Beaudin AE, Stover PJ (2007) Folate-mediated one-carbon metabolism and neural tube defects: balancing genome synthesis and gene expression. Birth Defects Res C 81:183–203
Blencowe H, Cousens S, Modell B, Lawn J (2010) Folic acid to reduce neonatal mortality from neural tube disorders. Int J Epidemiol 39(Suppl 1):i110–i121
Brazil (2012a) Painel de Monitoramento da Mortalidade Infantil e Fetal. http://svs.aids.gov.br/dashboard/mortalidade/infantil.show.mtw Accessed 12 Dec 2012
Brazil (2012b) Ministério da Saúde. SINASC (Sistema de Informações sobre nascidos vivos) http://www2.datasus.gov.br/DATASUS/index.php?area=0205 Accessed 12 Dec 2012
Brazil (2012c) Ministério da Saúde. SIM (Sistema de Informações de Mortalidade) http://www2.datasus.gov.br/DATASUS/index.php?area=040701 Accessed 12 Dec 2012
Bower C, Eades S, Payne J, D'Antoine H, Stanley F (2004) Trends in neural tube defects in Western Australia in Indigenous and non-Indigenous populations. Paediatr Perinat Epidemiol 18(4):277–280
Calvo EB, Biglieri A (2008) Impact of folic acid fortification on women's nutritional status and on the prevalence of neural tube defects. Arch Argent Pediatr 106(6):492–498
Castilla EE, Orioli IM (2004) ECLAMC: The Latin-American Collaborative Study of Congenital Malformations. Community Genet 7:76–94
Christianson A, Howson C, Modell B (2006) Global report on birth defects: the hidden toll of dying and disabled children. March of Dimes Birth Defects Foundation, New York
Cook RJ, Erdman JN, Hevia M, Dickens BM (2008) Prenatal management of anencephaly. Int J Gynaecol Obstet 102:304–308
Czeizel AE, Dudas I, Paput L, Banhidi F (2011) Review: prevention of neural-tube defects with periconceptional folic acid, methylfolate, or multivitamins? Ann Nutr Metab 58:263–271
Diniz D (2007) Selective abortion in Brazil: the anencephaly case. Dev World Bioeth 7(2):64–67
Diniz D, Penalva J, Faúndes A, Rosas C (2009) Anencephaly: the magnitude of the judicial authorization among medical doctors in Brazil. Ciênc Saúde Colet. doi:10.1590/S1413-81232009000800035
Elias MP, Monteiro LM, Chaves CR (2008) Accessibility of legal benefits available in Rio de Janeiro for physically handicapped people. Cien Saude Colet 13(3):1041–1050
Ferreira AF, Giugliani R (2008) Consumption of folic acid-fortified flour and folate-rich foods among women at reproductive age in South Brazil. Community Genet 11(3):179–184
Fonseca AC (2011) The fallacy of neutrality: the interruption of pregnancy of anencephalic fetus in Brazil. Bioethics 25(8):458–462
Greene NDE, Stanier P, Copp A (2009) Genetics of human neural tube defects. Hum Mol Genet 18:R113–R129
Groisman B, Liascovich R, Barbero P, Alberg C, Moorthie S, Nacul L, Sagoo GS (2013) The use of a toolkit for health needs assessment on neural tube defects in Argentina. J Community Genet 4:77–86
Horovitz DDG, Ferraz VEF, Dain S, Marques-de-Faria AP (2012) Genetic services and testing in Brazil. J Community Genet. doi:10.1007/s12687-012-0096-y
IBGE (2011) Fundação Instituto Brasileiro de Geografia e Estatística— Sinopse do Censo Demográfico 2010. http://www.ibge.gov.br/home/estatistica/populacao/censo2010/sinopse.pdf Accessed 12 Dec 2012
López-Camelo JS, Orioli IM, Da Graça Dutra M, Nazer-Herrera J, Rivera N, Ojeda ME, Canessa A, Wettig E, Fontannaz AM, Mellado C, Castilla EE (2005) Reduction of birth prevalence rates of neural tube defects after folic acid fortification in Chile. Am J Med Genet A 1;135(2):120–125
López-Camelo JS, Castilla EE, Orioli IM, INAGEMP (Instituto Nacional de Genética Médica Populacional); ECLAMC (Estudio Colaborativo Latino Americano de Malformaciones Congénitas) (2010) Folic acid flour fortification: impact on the frequencies of 52 congenital anomaly types in three South American countries. Am J Med Genet A 152A(10):2444–2458
Luquetti DV, Koiffman RJ (2010) Quality of birth defect reporting in the Brazilian Information System on Live Births (SINASC): a comparative study of 2004 and 2007. Cad Saude Publ Rio de Janeiro 26(9):1756–1765
Mezzomo CL, Garcias Gde L, Sclowitz ML, Sclowitz IT, Brum CB, Fontana T, Unfried RI (2007) Prevention of neural tube defects: prevalence of folic acid supplementation during pregnancy and associated factors in Pelotas, Rio Grande do Sul State, Brazil. Cad Saude Publica 23(11):2716–2726
Nacul LC, Stewart A, Alberg C, Chowdhury S, Darlison MW, Grollman C, Hall A, Modell B, Moorthie S, Sagoo GS, Burton H (2013) A toolkit to assess health needs for congenital disorders in low- and middle-income countries: an instrument for public health action. J Public Health. doi:10.1093/pubmed/fdt048
Orioli IM, Lima DO, Nascimento R, López-Camelo JS, Castilla EE (2011) Effects of folic acid fortification on spina bifida prevalence in Brazil. Birth Defects Res A Clin Mol Teratol 91(9):831–835
Santos LM, Pereira MZ (2007) The effect of folic acid fortification on the reduction of neural tube defects. Cad Saude Publica 23:17–24
Vercueil J (2010) Les pays émergents. Brésil-Russie-Inde-Chine. Mutations économiques et Transformations and new Challenges. Bréal, Paris, p 207
Victora CG, Aquino EM, do Carmo Leal M, Monteiro CA, Barros FC, Szwarcwald CL (2011) Maternal and child health in Brazil: progress and challenges. Lancet 377:1863–1876
Williams LJ, Mai CT, Edmonds LD, Shaw GM, Kirby RS, Hobbs CA, Sever LE, Miller LA, Meaney FJ, Levitt M (2002) Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 66:33–39
World Health Assembly (2010) Resolution EB126.R6. http://apps.who.int/gb/ebwha/pdf_files/EB126/B126_R6-en.pdf Accessed 12 Dec 2012
Zabala R, Waisman I, Corelli M, Tobler B, Bonora L, Cappato F, Cardetti M, Cervera M, Chepparo C, Costero A, Demarco R, Dieser P, Domínguez A, Dutto R, Encinas ME, Fiol AL, Gatica C, Giordano MA, González Achával D, González ML, Grassi C, Machi A, Martínez Colombres R, Meersohn M, Merlo M, Miranda D, Nanzer J, Núñez JM, Pedano L, Pérez Pazo A, Puscama A, Ramos ER, Rosso J, Rubio A, Santinelli I, Sfreddo A, Silenzi G, Sobral A, Trigo M, Tuninetti B, Urrea S, Zabala R (2008) Folic acid for neural tube defects prevention: consumption and information in fertil‐age women in Centro Cuyo Region. Arch Argent Pediatr 106(4):295–301
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Lavinia Schuler-Faccini and Maria Teresa V. Sanseverino have equally contributed to this manuscript.
Rights and permissions
About this article
Cite this article
Schuler-Faccini, L., Sanseverino, M.T.V., de Rocha Azevedo, L.M. et al. Health needs assessment for congenital anomalies in middle-income countries: Examining the case for neural tube defects in Brazil. J Community Genet 5, 147–155 (2014). https://doi.org/10.1007/s12687-013-0165-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12687-013-0165-x